MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/17.01.25 Share Price

Warrant

DE000ME85TR7

Real-time Bid/Ask 01:27:12 03/07/2024 pm IST
0.5 EUR / 0.54 EUR -3.70% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/17.01.25
Current month+3.85%
1 month-20.59%
Date Price Change
03/24/03 0.54 0.00%
01/24/01 0.54 +3.85%
28/24/28 0.52 0.00%
27/24/27 0.52 +30.00%
26/24/26 0.4 +2.56%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 12:23 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME85TR
ISINDE000ME85TR7
Date issued 05/02/2024
Strike 125 $
Maturity 17/01/2025 (199 Days)
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.97
Lowest since issue 0.37
Delta-0.38x
Omega 8.430
Premium6.63x
Gearing22.2x
Moneyness 0.9787
Difference Strike -2.72 $
Difference Strike %-2.18%
Spread 0.01
Spread %1.85%
Theoretical value 0.5250
Implied Volatility 21.11 %
Total Loss Probability 57.02 %
Intrinsic value 0.000000
Present value 0.5250
Break even 119.35 €
Theta-0.01x
Vega0.03x
Rho-0.02x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.7 USD
Average target price
142.7 USD
Spread / Average Target
+11.71%
Consensus